2021 MRM Talks: Dr. Massimiliano Paganelli and Kurtis Champion
The MRM Network presents: the MRM Talks. Join us every fourth Thursday at noon to learn more about stem cells and regenerative medicine. The webinar series will feature leading scientists in the field, including MRM Principal Investigators and external guest speakers.
For each seminar, we will also highlight the work of one MRM Trainee, who will present alongside our guest speaker.
In this edition of the MRM Talks:
Massimiliano Paganelli, M.D., Ph.D.
Associate professor, CHU Sainte-Justine, Université de Montréal
Co-founder and CEO, Morphocell Technologies Inc.
“Stem cell-derived encapsulated liver tissue: treating liver failure by allogeneic cell therapy without the need of immunosuppression”
Ph.D. Candidate in Prof. Corinne Hoesli’s Lab.
“Oxygen limitations and numerical modelling for islets in macroencapsulation devices for type 1 diabetes”
THURSDAY NOVEMBER 25, 2021
12:00 – 1:00 PM
Missed the presentation? You can catch up on our Youtube Channel. NOTE: This video is only available to MRM members. Please contact us at firstname.lastname@example.org to verify your status and request access to the recording.
About the speakers:
Clinician, scientist and entrepreneur, Massimiliano Paganelli is associate professor of pediatrics at the Université de Montréal and pediatric hepatologist and director of the Liver Tissue Engineering and Cell Therapy Laboratory at the CHU Sainte-Justine, in Montreal. After medical and pediatrics training at the University of Rome “La Sapienza” and subspecialty training in hepatology and liver transplantation at Cliniques Saint-Luc in Brussels (Belgium), he completed a Ph.D. at the Université catholique de Louvain. Recruited by the CHU Sainte-Justine in 2015 to continue his work on stem cell-based liver disease modelling and cell therapy, he is an FRQS Junior 2 clinician-scientist and his research is funded by the CIHR and Stem Cell Network, among others. He authored several papers and book chapters, filed various patent applications and was awarded prestigious national and international prizes. Dr. Paganelli is also co-founder and CEO of the regenerative medicine start-up company Morphocell Technologies Inc., which is developing stem cell-based therapies to treat adults and children with severe liver disease.
Kurtis Champion completed a Bachelor of Chemical Engineering in February 2021 at McGill University. He is currently a direct Ph.D. student in the Hoesli Laboratory whose project involves studying and modelling the oxygen consumption of the insulin-secreting beta cells of the pancreas found in cell clusters called islets. The main goal of his project is to improve oxygen delivery to these beta cells in the hopes of improving islet transplantation therapies for type 1 diabetes.
We want to hear from you, and we welcome your suggestions for speakers!
If you are interested in hosting an invited speaker, please get in touch with us.